CVS Pharmacy Now Offering New Shingles Vaccine at Locations Nationwide

More than 9,800 CVS Pharmacy locations have the Shingrix vaccine in stock for patients

News provided by

CVS Pharmacy

16 Mar, 2018, 08:30 ET

WOONSOCKET, R.I., March 16, 2018 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that all of its more than 9,800 pharmacies have the new Shingrix vaccine available for patients.1 The new vaccine was licensed by the U.S. Food and Drug Administration (FDA) in 2017 and is now recommended by the Centers for Disease Control and Prevention (CDC).

Healthy adults age 50 and older are recommended to get two doses of Shingrix, two to six months apart, to prevent shingles and reduce the course and severity of the disease. The Shingrix vaccine is considered more than 90 percent effective at preventing shingles and protection stays above 85 percent for at least the first four years after a patient is vaccinated.

Ninety-nine percent of people ages 50 and older are at risk of getting shingles, a painful rash that is also known as herpes zoster, in their lifetime. There are an estimated one million cases of shingles each year in the U.S. It is recommended that patients who have had shingles, have previously received the Zostavax vaccine,2 or who are unsure if they have had chickenpox, receive the Shingrix vaccine. Anyone who has recovered from chickenpox may develop shingles, including children, although the risk of shingles increases as people age.    

"Vaccination is key to preventing shingles and CVS Pharmacy is pleased to be able to provide patients with convenient access to this new and more effective vaccine," said Kevin Hourican, Executive Vice President, Pharmacy Services, for CVS Pharmacy. "Our pharmacists can help patients determine if Shingrix is right for them and can vaccinate patients at times and locations that work for their busy schedules."

Many health insurance plans will cover the new vaccine, including Medicare Part D. Patients are encouraged to contact their insurance provider to determine if and when their individual plan will cover the Shingrix vaccine. Patients can visit www.cvs.com to find nearby CVS Pharmacy locations and to learn more about the Shingrix vaccine and other immunizations CVS Pharmacy provides. Certain immunizations have age and location restrictions.

About CVS Pharmacy
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), is America's leading retail pharmacy with over 9,800 locations. It is the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry. CVS Pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS Pharmacy and CVS Health is available at www.cvshealth.com.

Media Contact          
Amy Lanctot
CVS Pharmacy
401-770-2931
[email protected]

1Due to state regulations, the Shingrix vaccine is currently not available at CVS Pharmacy locations in Florida.

2If a patient has recently received the Zostavax vaccine, they should wait at least eight weeks before receiving the Shingrix vaccine.

SOURCE CVS Pharmacy

Related Links

http://www.cvshealth.com

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.